Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, MD, USA.
Methods Mol Biol. 2022;2429:3-14. doi: 10.1007/978-1-0716-1979-7_1.
Human induced pluripotent stem cells (iPSCs) hold great promise for biomedical applications. However, establishment of new iPSC lines still presents many challenges. Here we describe a simple yet highly efficient two-step protocol for the isolation and purification of human iPSC lines. The first step adapts iPSCs to single cell culture and passaging, promoting survival and self-renewal; the second step enables the isolation and purification of bona fide iPSCs from a mixed population using column-based positive selection of cells expressing pluripotency markers such as TRA-1-60. Both steps utilize commercially available reagents. Using this protocol, iPSCs can be purified from cell preparations containing differentiated or unreprogrammed cells, or even be isolated directly from reprogramming vessels. The protocol could be adopted for high throughput isolation and expansion of iPSC lines and facilitate the widespread use of iPSCs in future applications.
人诱导多能干细胞(iPSC)在生物医学应用中具有巨大的潜力。然而,建立新的 iPSC 系仍然存在许多挑战。在这里,我们描述了一种简单而高效的两步法,用于分离和纯化人 iPSC 系。第一步使 iPSC 适应单细胞培养和传代,促进生存和自我更新;第二步使用基于柱的阳性选择方法,从混合群体中分离和纯化表达多能性标记物(如 TRA-1-60)的真正的 iPSC。这两步都使用市售试剂。使用该方案,可以从含有分化或未重编程细胞的细胞制剂中纯化 iPSC,甚至可以直接从重编程容器中分离 iPSC。该方案可用于高通量分离和扩增 iPSC 系,并促进 iPSC 在未来应用中的广泛使用。